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Abstract.  We have characterized the structure, biogen- 
esis, and localization of dipeptidyl aminopeptidase B 
(DPAP B), a  membrane protein of the yeast vacuole. 
An antibody specific for DPAP B  recognizes a  120-kD 
glycoprotein in yeast that behaves like an integral 
membrane protein in that it is not removed from mem- 
branes by high pH Na2COs  treatment. Inspection of 
the deduced amino acid sequence of DPAP B reveals a 
hydrophobic domain near the NH2 terminus that could 
potentially span a  lipid bilayer. The in vitro enzymatic 
activity and apparent molecular weight of DPAP B are 
unaffected by the allelic state of PEP4, a  gene essential 
for the proteolytic activation of a  number of soluble 
vacuolar hydrolases. DPAP B is synthesized as a 
glycosylated precursor that is converted to the mature 
120-kD  species by carbohydrate addition. The precur- 
sor form of DPAP B accumulates in sec mutants (No- 
vick, P., C.  Field, and R.  Schekman.  1980.  Cell. 
21:205-215)  that are blocked at the ER (sec18)  or 
Golgi apparatus (sec7), but not at secretory vesicles 
(secl).  Immunolocalization of DPAP B in wild-type or 
secl mutant cells shows that the protein resides in the 
vacuolar membrane.  However, it is present in non- 
vacuolar compartments in sec18 and sec7 cells, 
confirming that the delivery of DPAP B is blocked in 
these mutants. Interestingly, DPAP B appears to stain 
the nuclear envelope in a sec18 mutant, which is con- 
sistent with the accumulation of DPAP B  in the ER 
membrane at the restrictive temperature. These results 
suggest that soluble and membrane-bound vacuolar 
proteins use the same stages of the secretory pathway 
for their transport. 
T 
HE vacuole of the yeast Saccharomyces cerevisiae is 
considered to be  the equivalent of the lysosome of 
mammalian cells because it contains a large number 
of hydrolytic enzymes and has an acidic pH (reviewed in 
Rothman and Stevens,  1988).  The biosynthesis and sorting 
of soluble vacuolar hydrolases, such as carboxypeptidase Y 
(CPY) t and proteinase A, have been examined. The local- 
ization of soluble proteins to the vacuole requires the early 
stages of  the secretory pathway; i.e., ER and Golgi apparatus 
(Stevens et al., 1982). In addition, localization determinants 
on CPY and proteinase A, as well as genes necessary for the 
efficient sorting of these proteins, have been identified (Vails 
et al.,  1987; Johnson et al.,  1987; Klionsky et al.,  1988; 
Rothman and Stevens,  1986; Bankaitis et al., 1986;  Robin- 
son et al.,  1988;  Rothman et al.,  1989). 
Much less is known about the sorting of membrane pro- 
teins to the vacuole. Studies on mammalian cells indicate that 
soluble and membrane-bound lysosomal proteins are sorted 
J. H. Rothman's present address is MRC Laboratory of Molecular Biology, 
Hills Road, Cambridge CB2 2QH,  United Kingdom. 
1.  Abbreviations  used  in  this  paper:  CPY, carboxypeptidase  Y;  DPAP, 
dipeptidyl aminopeptidase; endo E  endoglycosidase F; N-linked, aspara- 
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by distinct mechanisms (von Figura and Hasilik, 1986). Sev- 
eral  lysosomal  membrane  proteins  have  been  identified 
(Chen et al.,  1985;  Lewis et al.,  1985;  Barriocanal et al., 
1986;  Lippincott-Schwartz and Fambrough,  1986; Waheed 
et  al.,  1988),  and  of those  examined,  none  possess  the 
mannose-6-phosphate moiety required for sorting soluble 
lysosomal proteins (yon Figura and Hasilik, 1986).  Further- 
more, several membrane proteins are found at normal levels 
in the lysosomes of I-cell fibroblasts, which missort soluble 
lysosomal hydrolases to the cell surface. 
Several activities associated with the vacuolar membrane 
of yeast have been  characterized  (Rothman and  Stevens, 
1988),  including transport  systems for Ca  2÷ (Ohsumi and 
Anraku, 1981) and basic amino acids (Ohsumi and Anraku, 
1983), a protein-translocating ATPase (Uehida et al., 1985; 
Kane et al., 1989), an ct-mannosidase (Opheim, 1978), and 
dipeptidyl aminopeptidase (DPAP) B (Suarez Rendueles et 
al., 1981; Julius et al., 1983; Bordallo et al., 1984). Nothing 
is known about the transport or posttranslational modifica- 
tions for any of the vacuolar membrane proteins. Analysis of 
the localization of ct-mannosidase and DPAP B in yeast mu- 
tants that missort soluble vacuolar proteins suggested that 
most  of these  mutants  do  not  missort  membrane-bound 
vacuolar  proteins  (Bankaitis  et  al.,  1986;  Rothman  and 
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unpublished results).  Thus,  soluble and membrane-bound 
proteins  appear  to  be  directed to the vacuole by distinct 
mechanisms. 
As a first step in the study of vacuolar membrane protein 
sorting and transport, we have characterized the structure, 
biogenesis, and localization of DPAP B. We show that DPAP 
B is an integral membrane protein that, like soluble vacuolar 
proteins, uses the early stages of the secretory pathway for 
its transport to the vacuole. 
Materials and Methods 
Strains, Growth Conditions, and Materials 
The genotypes of the Escherichia coli and S. cerevisiae strains used in these 
studies are listed in Table I. Yeast cultures were grown in minimal medium 
supplemented with the appropriate nutrients as previously described (Stev- 
ens et al.,  1986). 
Restriction endonucleases and other enzymes used for cloning and se- 
quencing were from New England Biolabs (Beverly, MA), Bethesda Re- 
search Laboratories (Gaithersburg, MD), Pharmacia Fine Chemicals (Pis- 
cataway,  NJ), or Boehringer Mannheim Biochemicals (Indianapolis, IN). 
125I-pmtein A  was  from Amersham Corp.  (Arlington Heights,  IL)  and 
carrier-free 35S-H2SO4 was from ICN Biomedicals Inc. (Irvine, CA). IgG 
Sorb was from The Enzyme Center (Boston, MA), endoglycosidase F (endo 
F) was from Boehringer Mannheim Biochemicals, and FITC-conjugated 
sheep anti-rabbit IgG was from Cappel Laboratories (Malvern, PA).  All 
other reagents used in these experiments were from Sigma Chemical Co. 
(St.  Louis, MO). 
Plasmid Constructions, Recombinant DNA 
Methodology, and DNA Sequence Analysis 
Restriction endonuclease and Bal 31  exonuclease digestions and ligations 
were performed as recommended by the suppliers.  Plasmid purification, 
agarose gel electmplforesis, and DNA-mediated transformation of E.  coil 
were performed according to standard procedures (Maniatis et al.,  1982). 
Plasmids were introduced into yeast cells by the lithium acetate transforma- 
tion method (Ito et al.,  1983). E. coli strain MC1061  was used for all plas- 
mid manipulations and JM103 was used for M13 phage work. 
DNA  sequencing was performed by the chain termination method of 
Sanger et al. (1977) using Ml3mpl8 and mpl9 vectors (Yanisch-Perron et 
al., 1985). In one case, sequencing was primed using a synthetic oligonucle- 
otide corresponding to nucleotides 441-459 of DAP2 (see Fig. 2), prepared 
at the University of Oregon  Biotechnology  Laboratory  on a  DNA  syn- 
thesizer (model 380B; Applied Biosystems, Inc.,  Foster City, CA) as de- 
scribed (Ito et al., 1982). DNA and amino acid sequence analyses were per- 
formed  using the sequence analysis software package (version 4) of the 
University of Wisconsin Genetics Computer Group. 
Plasmid pRG1  was constmc~xl by inserting the 4.7-kb Bam HI-Pst I 
(blunt-ended by treating with T4 DNA polymerase) DAP2 fragment (Fig. 
1), isolated from the original DAP2 plasmid YEpl3-GS13-4 (Julius et al., 
1983), into the Barn HI-Sma I sites of pUC12. Plasmid pGP3, a multicopy 
2-#m plasmid containing the DAP2 gene, was constructed by inserting the 
4.7-kb  Bam  HI-Pst  I  (blunt-ended)  fragment  from  pRG1  into the  Bam 
HI-Pvu II sites of YEp24. 
A  chromosomal  DAP2  deletion  was  constructed  by  transplacing  the 
genomic copy with the cloned gene into which the LEU2 gene was inserted 
in place of 1.3 kb of the DAP2 coding region (Rothstein, 1983; Fig. 1). Plas- 
mid pRGI was digested with BstE II and Kpn I, treated with T4 DNA poly- 
merase to make blunt ends, and ligated with a 2.1-kb Hpa I fragment con- 
taining the LEU2 gene. The resulting plasmid (pGP2) was cut with Barn HI 
and Pst I and used to transform the yeast strain JHRY20-2C (leu2-3, 1eu2- 
112).  Stable LEU+ transformants were purified and screened for the lack 
of thermolabile dipeptidyl aminopeptidase activity, assayed as described 
previously (Julius et al.,  1983). 
Plasmid pC  JR6, a multicopy 2-#m yeast vector containing the DPAP B 
coding region fused to the GAL/promoter, was constructed by inserting a 
400-bp Eco RI-Hind  III GAL/  promoter fragment (Johnston and Davis, 
1984) into the Eco RI and Hind III sites of pSEYS,  and subsequently sub- 
cloning into the Hind III site of this plasmid (pCJR5) the 2.9 kbp Hind IIl 
fragment of DAP2 (Fig.  1), resulting in the fusion of the GAL/ promoter 
at position  -90 of DAP2. 
DPAP B antigen for production of antiserum was made in E. coli by fus- 
ing a portion of the DAP2 coding region into the E. coli expression vector 
priSe5,  which contains the T4 phage lysozyme gene under the control of 
the TAC promoter (Muchmore et al.,  1988; kindly provided by R.  Dahl- 
quist, University of Oregon). Plasmid pRGI was digested with Stu I, treated 
briefly with Bal 31 exonuclease, and further digested with Hind III. Frag- 
ments of "~1,650 bp were cloned into the Sna BI-Hind III sites of priSe5, 
Table I.  Strains Used in This Study 
Yeast strain  Genotype  Source or reference 
X2180-1AL1  MATa gal2 lys2 mal reel  Derived  from X2180 
HMSF176  MATa secl8 gal2  Novick  et al.,  1980 
SF294-2B  MATa sec7 gal2  Novick and Schekman,  1983 
HMSFI  MATa secl gal2  Novick  et al.,  1980 
SEY5186  MATa secl8 ura3-52 leu2-3 leu2-112  Emr et al.,  1984 
CJRY21-3BAI  MATa secl8 ura3-52 leu2-3 leu2-112  This study 
metl4 adel ade2-1  trpl dap2-A2::LEU2  GAL  ÷ 
MATa secl ura3-52 leu2-3 leu2-112 
metl4 adel ade2-1 dap2-A2::LEU2  GAL  ÷ 
MATa sec7 ura3-52 leu2-3 1eu2-112 
met14 adel his3 dap2-A2::LEU2  GAL  ÷ 
MATa ura3-52 leu2-3 leu2-112 
his3-A200 lys2-801 pep4-3 can1  stel3-AI::LEU2 
MATa ura3-52 leu2-3 leu2-112 his3-A200 
MATa ura3-52 leu2-3 1eu2-112 
his3-A 200 pep4-A 2: :LEU2 
MATa ura3-52 leu2-3 leu2-112 
his3-A200 dap2-A2::LEU2 
CJRY22-6BAI  This study 
CJRY23-2AA1  This study 
JHRY20-1AA 1  Rothman,  1988 
JHRY20-2C 
JHRY20-2CA2 
JHRY20-2CA3 
E.  coli 
MC1061 
JMI03 
F- hsdR hsdM  ÷ araD139 (araABOlC-leu)7679 
(lac)X74 galU galK rpsL 
F' A (lac pro) thi strA endA sbcB15 supE/F' traD36 
proAB  ÷ laclq lacZaM15 
Rothman,  1988 
Derived  from JHRY20-2C 
Derived from JHRY20-2C 
Casadaban  and Cohen,  1980 
Messing,  1983 
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minal seven residues of T4 phage lysozyme fused to the COOH-terminal 
half of DPAP B. Transformants were screened for an isopropyl ~-D-thiogal- 
actopyranoside- (IPTG) inducible protein species by SDS-PAGE (Laemmli, 
1970) of total E.  coil cell extracts. A plasmid was isolated (pRG2) which 
produced a large amount (*5 % lof total cell protein) of  a 55-kD species upon 
induction with isopropyl B-D-thiogalactopyranoside. 
Production of DPAP B Antigen and Generation of 
DPAP  B Antiserum 
E. coil cells containing plasmid pRG2 were grown in LB broth plus ampicil- 
lin to saturation, then diluted 1:100 in 250 ml of fresh medium, and grown 
for 1 h at 37°C.  Isopropyl/~-D-thiogalactopyranoside was added to 1 mM, 
and incubation was continued for 3 h before collecting the cells by cenlrifu- 
gation. The cells were lysed and the fusion protein was isolated from the 
insoluble fraction essentially as previously described (Kleid et al.,  1981). 
An SDS-PAGE gel slice containing the fusion protein was resuspended in 
SDS elution buffer (1%  SDS, 50 mM Tris-HCI, pH 8.0,  1 mM EDTA,  1 
mM DTT,  100 mM NaCI) in a homogenizer (Dounce; Wheaton Instruments 
Div., Millville, NJ), incubated for 2 h at 37°C, and centrifuged at 12,000 g 
for 10 min. The supernatant was saved, and the pellet was resuspended in 
5 ml of elution buffer and treated as above. The supernatants were com- 
bined, and the protein was precipitated by adding 4 vol of acetone, incubat- 
ing for 30 min at  -80°C, and centrifuging at  15,000 g  for 10 rain. 
A DPAP B-specific antibody was prepared by injecting DPAP B antigen 
into New Zealand White Rabbits (250 ftg DPAP B antigen per rabbit per 
injection) essentially as described (Vaitukaitis,  1981). These antibodies 
were affinity purified as previously described (Stevens et aL, 1982). Antise- 
rum to phosphoglycerate kinase was prepared as described (Rothman et al., 
1986). 
Alkaline Sodium Carbonate Fractionation 
Yeast cells containing plasmid pGP3  were grown in minimal medium at 
30°C  to  mid  log  phase.  12  OD600 U  of cells  (1.2  ×  10  s  cells)  were 
spheroplasted as described previously (Stevens et al.,  1986),  lysed in 50 
mM sodium phosphate, pH Z5, 2  mM EDTA, and 0.5 mM PMSF, and 
diluted 100-fold in ice-cold 100 mM sodium carbonate, pH 11.5. An aliquot 
representing the whole extract fraction was removed, and after 30 rain on 
ice the lysate was centrifuged for 3 h at  100,000 g. The supernatant and 
whole extract fractions were neutralized with 1 N acetic acid, then precipi- 
tated in 5% TCA on ice. Precipitated protein was pelleted, washed twice 
in diethylether, dried, resuspended in sample buffer, and heated at 70°C un- 
til dissolved. The pellet fraction was homogenized in 50 mM Tris-HCl, pH 
6.8, and solubilized by addition of SDS to a final concentration of 4%. The 
sample was incubated at 60°C until complete solubilization had occurred; 
i.e., the suspension became completely transparent. Sample buffer (without 
SDS) was added, and the samples were subjected to SDS-PAGE on an 8% 
polyacrylamide gel. Electroblotting of the gel onto nitrocellulose was car- 
ried out according to Burnette (1981) using a Trans-blot Apparatus from Bio- 
Pad Laboratories (Richmond, CA). The transferred proteins were detected 
by probing the nitrocellulose with antibodies to the appropriate antigens and 
subsequent labeling with 0.3  #Ci of IzSI-protein  A. The dried nitrocellu- 
lose was exposed to film (XAR-5; Eastman Kodak Co., Rochester, NY) at 
-80°C. 
Radiolabeling, Immunoprecipitation, 
and Endo F Treatment 
Yeast cells were grown in minima[ media plus 50 tzM Na2SO4 (Stevens et 
al., 1986) to midlog phase, spun down in a clinical centrifuge, washed once 
and resuspended in sulfate-free media, and  incubated at the appropriate 
labeling temperature  for  15-30  min  at  8  OD6o0 U/ml.  35S-H~SO4 was 
added (0.5-1.0 mCi) and cells were labeled and then chased with 10 mM 
Na2SO4 (except for the experiments in Fig. 5 B, which were chased with 
10 mM Na~SO4,  1 mM cysteine, 1 mM methionine, and 0.1 mg/ml cyclo- 
heximide). 20D60o U of cells were then sedimented, converted to sphero- 
plasts, and lysed in 0.1 ml of 1% SDS by heating for 3 min at  100°C.  0.9 
ml of immunoprecipitation buffer (Stevens et al., 1986) was added, followed 
by 0.1  ml of IgG Sorb (prepared as suggested by the manufacturer). The 
mixture  was  centrifuged  15  min  in  a  microfuge (model  235B;  Fisher 
Scientific Co., Pittsburgh, PA) and the supernatant was treated with 2/~1 
of affinity purified DPAP B antibody and incubated 60 min on ice. The im- 
mune complexes were sedimented with IgG Sorb and washed as before 
(Stevens et al.,  1982),  and the final  IgG Sorb cell pellet was resuspended 
in 0.1 ml of 1% SDS and heated 3 min at 100°C. 0.9 ml of immunoprecipita- 
tion buffer and 0.1 ml of IgG Sorb was added, and the immunoprecipitation 
protocol was repeated. Sample buffer was added to the final IgG Sorb pellet 
and the samples were heated for 3 min at 100°C and centrifuged. Superna- 
tant fractions were transferred to new tubes and aiiquots (normalized for the 
amount  of 35S-H2SO4 incorporated)  were  analyzed  by  SDS-PAGE and 
fluorography as described previously (Stevens et al.,  1986). 
Endo F treatment (Elder and Alexander, 1982) was carried out on immu- 
noprecipitated samples of DPAP B essentially as described (Stevens et al., 
1986).  A time course of endo F treatment was performed by adding 300 
mU ofendo F to DPAP B immunoprecipitated from SEY5186 cells (contain- 
ing plasmid pGP3) and withdrawing aliquots at the times indicated in Fig. 6. 
lmmunofluorescence Microscopy 
Yeast cells containing a disruption of the chromosomal DAP2  locus and 
transformed with the plasmid pC  JR6 were grown in minimal media plus 2% 
raffinose to an OD600 of 1.0, and galactose was added directly to the cul- 
tures to a final concentration of 3%. The cultures were then incubated at 
either 34°C (SEC  +, secl8, and secl) or 38°C (SEC  + and secT) for 2 h and 
the cultures were  put on  ice.  The cells were  fixed with  formaldehyde, 
spheroplasted, and prepared for immunofluorescence  as described (Kilmar- 
tin and Adams, 1984; Adams and Pringle, 1984; Wittenberg et al.,  1987). 
In some cases, fixed spheroplasts were treated with SDS by resuspending 
in 1 ml of 1.2 M sorbitol/PBS (prepared as described by Adams and PringIe, 
1984) plus 5 % SDS, mixed gently, centrifuged at 8,000 g, and washed twice 
in 1.2 M sorbitol. FITC-conjugated sheep anti-rabbit IgG second antibody 
was used for staining DPAP B  antibody.  Nuclei  were stained with 4'6- 
diamidino-2-phenyl-indole (DAPI)  as described (Kilmartin and  Adams, 
1984). 
Cells were viewed and photographed using a Zeiss Axioplan Photomicro- 
scope (equipped for epifluorescence at excitation wavelengths appropriate 
for DAPI and FITC  fluorescence) and film and developer (TMAX-400; 
Eastman Kodak Co.). Photomicrographs are shown at a magnification of 
1,000. 
Results 
The DAP2 Gene Encodes DPAP B 
Yeast  cells contain two membrane-associated  DPAP activi- 
ties that differ in their subcellular locations and thermal sta- 
bilities (Suarez Rendueles et al.,  1981; Julius et al.,  1983). 
DPAP B is a thermolabile enzyme associated with the vacuo- 
lar membrane (Bordallo et al.,  1984).  DPAP A, the STE/3 
gene product, is a nonvacuolar, heat-stable enzyme that par- 
ticipates in the proteolytic maturation of the mating phero- 
mone a-factor (Fuller et al.,  1988).  The STE/3  gene  was 
cloned by complementation of the mating defect of a MATs 
s  s 
lO0"bp 
Figure 1. Restriction map and nucleotide sequencing strategy of the 
DAP2 gene. A  linear map of the DAP2 gene is depicted, with the 
horizontal arrows indicating direction and extent of sequence deter- 
mination. The arrow originating in a solid circle corresponds to se- 
quence determined from DNA synthesis primed by a synthetic oli- 
gonucleotide.  The boxed region denotes the open reading frame, 
with the predicted initiating methionine codon at the left end. The 
hatched  region  shows the portion  of DAP2  coding  sequence re- 
placed by LEU2 sequences in the dap2-A2::LEU2 disruption (see 
Materials and Methods). Restriction sites that are relevant to the se- 
quence analysis are indicated: B, Barn HI; H,  Hind III; A, Ace I; 
Bs, BstE II; S, Stu I; K, Kpn I; E, Eco RI; He,  Hinc II; P, Pst I. 
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-240 
-120 
1  ATG 
1  Met 
91  ~ 
311Gly 
181  A~C 
6]  ASh 
271  TGG 
91  Trp 
361  GAC 
121  ASp 
451  CTG 
151  Leu 
541  TCC 
181  Set 
631  TAT 
211  Tyr 
721  GAA 
241  GIu 
811  GAG 
271  Glu 
901  CCT 
301  Pro 
991  ATT 
331  lle 
1081  ACA 
361  ThE 
1171  AAT 
391  A~n 
1261  AGT 
421  Set 
1351  ATT 
451  Ile 
1441  GAG 
481  GIu 
1531  GTG 
511  Val 
1621  ACC 
541  Thr 
1711  Ace 
571  Ash 
1801  CAA 
601  Gln 
1891  ACT 
631  Thr 
1981  TAT 
661  Tyr 
2071  GAT 
691  Asp 
2161  CAT 
721  His 
2251  CAC 
751  His 
2341  CAC 
981  His 
2431 
811 
2521 
84] 
2639 
BamHl 
-458  GGATCCTGTTTGTGGTAGTGGTTCTGTAGCCCTTGCAAGATATTTGCAAGAAGTTTATAAGTTTGAGAAAACCACGGATATTACCATTTCTGAGGGTG 
GAAGGTTAAAAAGAAATGGCCTAATGTTAGCTTCAATTAAGAAAGAAGCTGATAATAGCACTTCCTACTATATAGCAGGTCATGCCACTACCGTTATTGATGGTAAGATcAAAGTTTAGG 
ATTCTAAAcGCATAGTTGTAAGGTTGATGTATATATATATATATATATGTATATATTAATTACAATAATATGCTCCCGCCCAAATTTTTCTCCTTCAATACCGCCGGAGGCGGTATTGAA 
HindlII 
GGAAATAGAcGGAGAATTccTTATCAAGAAAGCTTccATCAAAGTGTACATAAGAAGTGCCGAAATTcGAAGTATTCTTTcAGAGAGTATTTTTGCAACATAC•AATAAGccAAATTACTC 
GAA  GGT  GGC  GAA  GAA  GAA  GTT  GAG  CGC  ATT  CCT  GAT  GAA  CTT  TTC  GAT  ACA  AAA  AAG  AAG  CAT  TTG  TTA  GAT  AAG  CTC  ATA  AGG  GTC 
GIu  Gly  Gly  Glu  GIu  GIu  Val  GIu  Arg  Ile  Pro Asp  Glu  Leu  Phe  Asp  Thr  Lys  Lys  Lys  Hls  Leu  Leu  Asp  Lys  Leu  Ile  Arg o 
Accl 
ATA ATC  CTT  GTA  CTC  CTG  ATA  TGG  GGC  ACT  GTT  TTG  TTG  CTA  AAA AGT  ATA  CCT  CAC  CAT  TCA  AAC  ACA  CCA  GAT  TAT  CAA  GAA  CCC 
Ile  Ile  Leu  Val  Leu  Leu  Ile,Tr~  GI~  Thr  Val  Leu  Leu  Leu[Lys  ser  Ile  Pro  His  His  Set  Ash  Thr  Pro  Asp  Tyr  Gin  Glu  Pro 
TCT  AAT  TAC  Ace  AAT  GAT  GGG  AAA  TTA  AAG  GTG  TCG  TTT  TCT  GTT  GTA  AGA  AAC  AAT  ACA  TTT  CAT  CCC  AAA  TAT  CAC  GAG  CTG  CAA 
Set  A~n  Tyr  Thr  Asn  Asp  Gly  Lys  Leu  Lys  Val  SeE  Phe  Set  Val  Val  Arg  A~n  Ash  Thr  Phe  His  Pro  LFS  Tyr  His  GIu  Leu  Gln 
ACCI 
ATT  AGT  GAC  AAT  AAA  ATT  GAA  AGC  AAC  GAT  CTA  GGT  CTT  TAT  GTT  ACA  TTT  ATG  AAC  GAT  AGT  TAC  GTT  GTT  AAA  TCT  GTC  TAC  GAT 
lle  Set  Asp  ASh  Lys  Ile GIu  Set  ASh  Asp  Leu  Gly  Leu  Tyr  Val  Thr  Phe  Met  A~n  Asp  SeE  Tyr  Val  Val  Lys  Set  Val  Tyr  Asp 
TCA  TAT  AAT  AAC  GTT  TTA  TTA  GAG  GGA  AAA  ACT  TTC  ATT  CAT  AAC  GGT  CAA  AAC  CTC  ACT  GTG  GAG  TCA  ATA  ACT  GCG  TCT  CCC  GAC 
Set  Tyr  ASh  Ash  Val  Leu  Leu  Glu  Gly  Lys  ThE  Phe  lie  His  Ash  Gly  Gln  A~n  Leu  Thr  Val  GIU  Ser  lle Thr  Ala  Set  Pro  Asp 
Accl 
AAG  CGG  TTA  TTA  ATT  AGA ACA  AAT  AGe  GTA  CAA  AAT  TGG  AGA  CAC  TeA  ACG  TTT  GGT  TCT  TAT  TTT  GTC  TAC  GAT  AAG  AGT  AGe  TCG 
Lys  Arg  LeU  Leu  lle  Arg  Thr  Ash  Set  Val  Gin  Asn  Trp  Arg  His  SeE  Thr  Phe  Gly  Set  Tyr  Phe  Val  Tyr  Asp  Lys  Set  Set  Set 
TTG  AGG  AGA  TTG  GAA  ACA  GTG  GCT  eTA  GCA  ATA  TGG  TCC  CCT  AAT  TCT  AAT  AAT  ATT  GCA  TAC  GTC  CAA  GAT  AAC  AAT  ATA  TAT  ATT 
Leu  Arg  Arg  Leu  Glu  Thr  Val  Ala  Leu  Ala  lie  Trp  Set  Pro  ASh  Set  ASh  Ash  lie  Ala  Tyr  Val  Gin  Asp  Ash  ASh  lie  Tyr  lie 
TCT  GCT  ATT  TCC  AAA  AAG  ACC  ATA  CGG  GCT  GTG  Ace  AAC  GAC  GGA  AGC  TCC  TTT  CTT  TTT  AAC  GGT  AAG  CCA  GAT  TGG  GTT  TAC  GAG 
Set  Ala  lle  SeE  Lys  Lys  Thr  Ile  Arg  Ala  Val  Thr  Ash  Asp GIy  Set  Ser  Phe  Leu  Phe  ASh  Gly  Lys  Pro  Asp  Trp  Val  Tyr  Glu 
BStEII 
GAA  GTT  TTT  GAA  GAC  GAC  AAG  GCT  GCG  TGG  TGG  TCA  CCA  ACT  GGT  GAT  TAC  CTG  GCA  TTC  TTG  AAA  ATT  GAT  GAA  TCA  GAA  GTT  GGT 
GIU  Val  Phe  Glu  Asp  Asp  Lys  Ala  Ala  Trp  Trp  Set  Pro  Thr  Gly  Asp  Tyr  Leu  Ala  Phe  Leu  Lys  lle  Asp  GIU  Set  Glu  Val  Gly 
TTT  ATC  ATT  CCA  TAT  TAT  GTC  CAA  GAT  GAA  AAG  GAT  ATA  TAC  CCC  GAA  ATG  CGC  AGT  ATC  AAG  TAT  CCA  AAA  AGT  GGC  ACG  CCA  AAT 
Phe  Ile  Ile  Pro  Tyr  Tyr  Val  Gin  Asp  GIu  Lys  Asp  lle  Tyr  Pro  Glu  Met  Arg  SeE  Ile  Lys  Tyr  Pro  Lys  Ser  Gly  Thr  Pro  ASh 
CAT  GCA GAG  CTA  TGG  GTT  TAC  AGT  ATG  AAA  GAT  GGA  ACA  TCG  TTC  CAT  CCA  AGA  ATA  AGT  GGA  AAT  AAA  AAA  GAT  GGA  AGT  CTG  TTA 
His  Ala  Glu  Leu  Trp  Val  Tyr  Set  Met  Lys  Asp Gly  Thr  Set  Phe  His  Pro  Arg  Ile  Set  Gly  Asn  Lys  Lys  Asp  Gly  SeE  Leu  Leu 
ACT  GAA  GTT  ACA  TGG  GTA  GGA  AAT  GGA  AAC  GTT  TTA  GTT  AAA  ACT  ACC  GAT  CGA  TCC  TCG  GAC  ATA  TTG  ACT  GTG  TTT  TTG  ATA  GAT 
Thr  Glu  Val  Thr  Trp  Val  Gly  Asn  Gly  ASh  Val  Leu  Val  Lys  Thr  Thr  Asp  Arg  Ser  Set  Asp  Ile  Leu  Thr  Val  Phe  Leu  lle  Asp 
ATT  GCC  AAA  GAC  TTC  AAA  CGT  GGT  AAG  GAA CGA  AAG  TTT  AAC  GGA GGA  TGG  TGG  GAG  ATT  ACT  CAT  AAT  ACT  CTG  TTT  ATT  CCG  GCA 
lle  Ala  Lys  Asp  Phe  Lys  Arg  GIy  Lys  GIu  Arg  Lys  Phe  ASh  Gly  Gly  Trp  Trp GIu  lie  Thr  Hls  Ash  ThE  Leu  Phe  lie  Pro  Ala 
Stul 
GAA  ACA  TTT  GAT  AGG  CCT  CAT  AAT  GGT  TAT  GTT  GAT  ATT  CTT  CCG  ATT  GGT  GGT  TAC  AAT  CAT  TTG  GCT  TAT  TTC  GAA  AAT  AGT  AAT 
GIu  Thr  Phe  Asp  Arg  Pro  His  Asn  Gly  Tyr  Val  Asp  lle  Leu  Pro  Ile  GIF  Gly  Tyr  Ash  His  Leu  Ala  Tyr  Phe  Glu  Asn  Set  A~n 
TCA  CAC  TAT  AAA  ACA  TTG  ACA  GAG  GGG  AAA  TGG  GAA  GTG  GTG  AAT  GGC  CCA  CTT  GCC  TTT  GAT  TCA  ATG  GAA  AAT  CGT  CTT  TAC  TTC 
Set  His  Tyr  LFs  Thr  Leu  Thr  GIu  Gly  Lys  Trp  GIu  Val  Val  ASh  Gly  Pro  Leu  Ala  Phe  Asp  Set  Met  GIu  Asn  Arg  Leu  Tyr  Phe 
BstEII 
TCT  ACA  CGA  AAG  AGT  TCA  ACC  GAA  CGC  CAC  GTT  TAC  TAC  ATA  GAT  TTA  CGG  TeA  CCA  AAT  GAA  ATT  ATT  GAA  GTT  ACT  GAT  ACT  TCT 
Ser  Thr  Arg  Lys  Ser  Set  Thr  GIu  AEg  His  Val  Tyr  Tyr  lle  Asp  Leu  Arg  $er  Pro  Asn  Glu  lle  Ile  Glu  Val  Thr  Asp  Thr  Ser 
GAT  GGT  GTC  TAT  GAT  GTG  TCC  TTT  TCT  TCT  GGT  AGA  AGG  TTT  GGT  TTA  CTC  ACC  TAT  AAA  GGA  CCA  AAA  GTT CCA  TAT  CAA  AAA  ATT 
Asp Gly  Val  Tyr  Asp  Val  Set  Phe  Set  5er  Gly  Arg  Arg  Phe  Gly  Leu  Leu  Thr  Tyr  Lys  Gly  Pro  Lys  Val  Pro  Tyr  Gln  Lys  lie 
GAC  TTC  CAT  TCT  CGT  AAA  GCA  GAA  AAA  TGC  GAC  AAA GGT  AAT  GTT  TTA  GGC  AAA  TeA  CTA  TAC  CAT  TTG  GAA  AAG  AAC  GAA  GTA  CTT 
Asp  Phe  His  Set  Arg  Lys  Ala  GIu  Lys  Cys  Asp  Lys  Gly  ASh  Val  Leu  Gly  Lys  SeE  Leu  Tyr  His  Leu  Glu  Lys  ASh  GIu  Val  Leu 
K~nl 
AAA  ATT  TTA  GAA  GAT  TAT  GCG  GTA CCC  AGA  AAA  TCA  TTC  AGG  GAA  TTG  AAC  CTA  GGA  AAG  GAC  GAA  TTT  GGA  AAG  GAT  ATA  eTA  GTG 
Lys  Ile  Leu  Glu  Asp Tyr  Ala  Val  Pro  Arg  Lys  Set  Phe  Arg  Glu  Leu  ASh  Leu  Gly  Lys  Asp  GIU  Phe  Gly  Lys  Asp  Ile  Leu  Val 
£CoRI 
TCG  TAT  GAA  ATC  CTA  CCA  AAT  GAT  TTC  GAT  GAA  ACG  TTA  AGT  GAC  CAC  TAT  CCT  GTA  TTT  TTC  TTT  GCA  TAT  GGG  GGA  CCG  AAT  TCT 
Set  Tyr  GIu  Ile  Leu  Pro  ASh  Asp  Phe  Asp  Glu  Thr  Leu  Set  Asp  His  Tyr  Pro  Val  Phe  Phe  Phe  Ala  Tyr  Gly  Gly  Pro  ASh  Set 
CAA  GTT  GTC  AAA  ACG  TTT  TCC  GTA GGA  TTT  AAT  GAA  GTG  GTA  GCT  TCA  CAA  TTA  AAC  GCA  ATT  GTA  GTT  GTT  ~TT  GAC  GGT  CGT  GGT 
Gln  Val  Val  Lys  Thr  Phe  Set  Val  Gly  Phe  Asn  Glu  Val  Val  Ala  Set  Gln  Leu  Ash  Ala  Ile  Val  Val  Val  Val  Asp  Gly  Arg  Gly 
GGC  TTC  AAA  GGT  CAA  GAC  TTT  AGA  TCC  CTT  GTT  CGC  GAT  AGG  CTC  GGT  GAT  TAC  GAG  GCC  CGC  GAC  CAA  ATA  TCT  GCG  GCT  TCC  TTA 
Gly  Phe  Lys  G!y  Gln  Asp  Phe  Arg  Set  Leu  Val  Arg  Asp  Arg  Leu  Gly  Asp  Tyr  Glu  Ala  Arg  Asp  Gln  Ile  Ser  Ala  Ala  Ser  Leu 
KpnI 
GGT  TCT  TTA  ACT  TTT  GTT  GAT  CCG  CAA  AAG  ATT  TCC  TTA  TTT  GGT  TGG  TeA  TAC  GGG  GGG  TAC  CTG  gcg  CTA  AAA  ACT  TTG  GAG  AAA 
Gly  Set  Leu  Thr  Phe  Val  Asp  Pro  Gin  Lys  lie  Set  Leu  Phe  Gly  Trp  Ser  Tyr  Gly  Gly  Tyr  Leu  Thr  Leu  Lys  Thr  Leu  GIu  Lys 
GGC  GGA  AGA  CAT  TTC  AAA  TAC  GGG  ATG  TCA  GTT  GCG  CCA  GTA ACC  GAC  TGG  AGA  TTT  TAC  GAT  TCT  GTT  TAT  ACT  GAG  AGG  TAC  ATG 
Gly  GIy  Arg  His  Phe  Lys  Tyr  Gly  Met  SeE  Val  Ala  Pro  Val  Thr  Asp  Trp  Arg  Phe  Tyr  Asp  $er  Val  Tyr  Thr  Glu  Arg  Tyr  Met 
ACT  CCT  CAA  GAA  AAC  TTT  GAT  GGA  TAC  GTA  GAA  TCA  AGe  GTT  CAT  AAT  GTC  ACT  GeT  TTG  GCA  CAA  GCA  AAT  AGA  TTT  TTG  TTG  ATG 
ThE  Pro  Gin  Glu  Asn  Phe  Asp  Gly  Tyr  Val  Glu  Set  Set  Val  His  A~n  Val  Thr  Ala  Leu  Ala  Gln  Ala  Ash  Arg  Phe  Leu  Leu  Met 
Hincll 
GGA  ACA  GGA  GAT  GAT  AAC  GTT  CAC  TTT  CAA  AAT  TCC  CTA  AAG  TTT  CTG  GAC  CTT  TTG  GAT  CTA  AAT  GGT  GTG  GAA  AAT  TAT  GAC  GTC 
Gly  Thr  Gly  Asp  Asp  Ash  Val  His  Phe  Cln  Ash  Set  Leu  Lys  Phe  Leu  Asp  Leu  Leu  Asp  Leu  Ash  Gly  Val  Glu  ASh  Tyr  Asp  Val 
GTC  TTT  CCT  GAC  TCA  GAT  CAT  AGT  ATA  AGA  TAC  CA'I AAT  GCG  AAT  GTA  ATC  GTT  TTT  GAC  AAG  CTA  TTG  GAT  TGG  CAA  AGC  GTG  CTT 
Val  Phe  Pro  Asp  Set  Asp  His  Set  lle  Arg  Tyr  His  ASh  Ala  Ash  Val  lie  Val  Phe  Asp  Lys  Leu  Leu  Asp  Trp  Gln  Set  Val  Leu 
TCG  ATG  GGC  AAT  TTG  ACA  AAT  GAG  TTG  ACT  ATT  TAC  AGC  TeA  TCT  CAT  AGA  GAC  ATT  CAT  AAA  ACA  TTT  TeA  TAT  TTA  CAT  ACT  ATG  TAT 
Set  Met  Gly  A~n  Leu  Thr  Asn  Glu  Leu  Thr  lle  Tyr  Set  Set  Set  His  Arg  Asp  Ile  Hls  Lys  Thr  Phe  Set  Ty[  Leu  His  Thr  Met  Tyr 
ATA  TAA  AATTGGTAATATAACAGATTAA•GTT•GTAGAAGATGATGTGTTTTACGGTGGCAAAAGGCGAGCACGAAATTTGGCAAAGGGTATAAGTAATTAAGCAAATTTGGTCAAAT 
lle  End 
ACCI 
CTATAATTCTTCACTAACAAACTTGCCCATTGGTCTAC 
Figure 2. Nucleotide and corresponding amino acid sequence of the DAP2 gene. Nucleotide residues are numbered in the 5'- to -3' direction, 
with the A of the predicted ATG initiating methionine given the number 1. The restriction sites used in sequencing are indicated. The TATA- 
like element is underlined,  the amino acids  comprising the putative  membrane-spanning  domain are boxed,  and the potential  sites  of 
N-linked glycosylation  are marked by asterisks. 
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results;  Julius  et al.,  1983).  Another gene,  called STE/Y 
(also called DPP2), was cloned by its ability to complement 
the or-factor  maturation defect of a  ste13 mutant when ex- 
pressed from a high copy number plasmid (Sprague, G., and 
I. Herskowitz, unpublished results; Julius et al.,  1983). The 
gene dosage of DPP2 had a direct effect on the specific activ- 
ity of DPAP B in extracts of yeast cells (Julius et al.,  1983; 
Sprague, G., unpublished results). Strains transformed with 
a multicopy plasmid containing DPP2 on a 4.7-kb Bam HI- 
Pst I fragment (Fig. 1) showed a 10-20-fold increase in DPAP 
B  activity,  whereas  strains  carrying a  disrupted  genomic 
copy of DPP2 (dpp2-za2::LEU2, see Materials and Meth- 
ods; see Fig. 4) showed no measurable DPAP B activity in 
assays of whole cell extracts (data not shown). Also, a dpp2- 
A2::LEU2/DPP2 diploid strain had •50%  of the DPAP B 
activity of a DPP2/DPP2 diploid (data not shown). 
Mutants deficient in DPAP B activity have been previously 
described (Suarez Rendueles and Wolf,  1987).  These mu- 
tants,  including  one  with  an  exceptionally  thermolabile 
DPAP B activity, harbored mutations that fell into a single 
complementation group, called DAP2, and failed to comple- 
ment the dpp2-za2 mutation. Thus, DPP2 and DAF2 define 
the same locus, which encodes DPAP B. Henceforth, DAP2 
will denote the gene encoding DPAP B. No phenotype other 
than the lack of DPAP B was observed in strains disrupted 
at the DAP2 locus (Sprague, G., unpublished results; data 
not shown), consistent with the results of Suarez Rendueles 
and Wolf (1987). 
A 
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Figure 3. Hydrophobicity analysis of the DAP2 gene product. (A) 
The mean hydropathic index of successive stretches of 19 amino 
acid residues is plotted vs. the amino acid number of the middle 
residue of  each stretch. Regions with high positive values are poten- 
tial membrane spanning domains. (B) Model of the membrane to- 
pology of DPAP B predicted from the deduced amino acid se- 
quence. The NH2- and COOH-terminal ends of the protein are 
indicated, and the sites for N-linked glycosylation are marked by 
triangles. 
Primary Structure of  DPAP  B Deduced from the 
DAP2 Sequence 
We deduced the primary structure of DPAP B by sequencing 
DAF2. Fig. 1 shows the restriction map of DAP2 and the se- 
quencing strategy for the 3,135-bp Barn HI-Acc I fragment. 
The complete nucleotide and deduced amino acid sequences 
are presented in Fig. 2. 459 bp of 5' and 153 bp of 3' flanking 
sequences are included in addition to the 2,523 bp of coding 
sequence. 
Translation of DPAP B is predicted to initiate at the methi- 
onine codon numbered  1 (Fig.  2).  The sequenced region 
contains a long open reading frame coding for a protein of 
841 amino acids, with eight canonical sites for asparagine- 
linked  (N-linked) glycosylation. A  24-bp segment located 
from -210 to -187 relative to the putative translation initiat- 
ing codon may function as a reiterated TATA-Iike box for ini- 
tiation of transcription. An identical sequence is found in a 
similar location upstream of the yeast STE3 gene (Hagen et 
al., 1986). The predicted molecular mass from the deduced 
amino acid sequence is 96,429 D, which is similar to the ap- 
parent molecular mass of DPAP B after removal of N-linked 
carbohydrate (see below). 
Hydropathy analysis of the amino acid sequence (Kyte and 
Doolittle, 1982; Fig. 3 A) reveals a single hydrophobic do- 
main,  beginning  30  residues  from the  NHz terminus,  of 
sufficient length and hydrophobicity to span a lipid bilayer 
(Adams and Rose, 1985; Davis and Model, 1985). Thus, the 
predicted topology of DPAP B is that of a type II (or group 
B;  Fig.  3  B)  integral  membrane  protein  (Garoff,  1985; 
Singer et al.,  1987), with an NH2-terminal cytoplasmic do- 
main and a lumenal COOH terminus. The hydrophobic do- 
main presumably functions as both an ER-targeting signal 
and a membrane anchor, as is true of other type II integral 
membrane proteins, such as the neuraminidase of influenza 
virus (Bos et al.,  1984) and the transferrin receptor (Zerial 
et al.,  1986). Further support for this disposition of DPAP 
B in the membrane is the observation that DPAP B is a glyco- 
protein (see below), and that all sites for N-linked glycosyla- 
tion  are  included  in  the  COOH-terminal  domain,  which 
therefore must be the lumenal domain. 
No significant sequence similarity has been found between 
DPAP B and any other vacuolar or tysosomal protein for 
which  sequence information is available.  However, strong 
homology has been found between DPAP B and DPAP A, 
the product of the STE/3 gene (Flanagan, C., and J. Thorner, 
personal communication; see below). 
DPAP  B Is a 120-kD Integral Membrane Protein 
To facilitate the biochemical characterization of DPAP B, a 
DPAP B-specific antibody was prepared (see Materials and 
Methods).  Lanes 1 and 2 of Fig. 4  show that the antibody 
is  specific for the DAP2 gene product in  yeast.  Isogenic 
DAP2 and dap2-A2 cells were labeled with 355-H2804  for 
30 min and chased for 30 min in the presence of 10 mM 
NazSO4,  and  immunoprecipitations were performed from 
cell extracts. Two species were precipitated from the DAP2 
strain (Fig. 4, lane 2):  a major species of ,x,120 kD and a 
lesser amount of a  ll0-kD form. Both of these bands were 
absent from the dap2-za2 strain (lane/), indicating that they 
represent the products of the DA/~ locus. 
Roberts et al.  Biogenesis  of a  Yeast  Vacuolar Membrane Protein  1367 Figure 4. Immunoprecipitations of DPAP B. (Lanes 1 and 
2) JHRY20-2CA3 (A) and JHRY20-2C (+) cells  were 
35S labeled for 30 min and chased  30 min in the pres- 
ence of Na2SO4. (Lanes  3-10) JHRY20-2C cells  were 
pulse  labeled  for  5  min  and  chased  in  unlabeled 
Na2SO4, cysteine,  methionine,  and  cycloheximide  for 
the times indicated.  Labeled cells were collected,  con- 
verted to spheroplasts, lysed in 1% SDS, and immunopre- 
cipitated  with  DPAP B  antibody. Immunoprecipitates 
were analyzed on 6% polyacrylamide SDS gels without 
(-Endo F) or with (+Endo F) earlier treatment  with 
endo E 
The deduced amino acid sequence predicts that DPAP B 
is an integral membrane protein. To test this prediction bio- 
chemically, yeast spheroplasts were treated with 100 mM so- 
dium carbonate, pH 11.5, and centrifuged at 100,000 g. Un- 
der these conditions, only intrinsic membrane proteins pellet 
with membranes, whereas soluble and peripheral membrane 
proteins  are  recovered in  the  supernatant  (Steck  and  Yu, 
1973; Fujiki et al., 1982). Fig. 5 shows western blot analysis 
of the total,  pellet,  and  supernatant  fractions using DPAP 
B-specific and phosphoglycerate kinase- (PGK) specific an- 
tibodies.  The DPAP B antigen was found in the membrane 
fraction, whereas the soluble protein PGK did not sediment 
with membranes. These data confirm that DPAP B is an inte- 
gral membrane protein. 
DPAP B Is Synthesized as a Glycosylated Precursor 
The soluble vacuolar proteins analyzed to date, such as CPY, 
are  synthesized  as  glycoproteins  (Rothman  and  Stevens, 
1988). CPY first appears as a glycosylated precursor which 
receives further glycosyl residues in the Golgi apparatus be- 
fore being proteolytically cleaved to the mature form upon 
delivery to the vacuole (Stevens et al.,  1982).  To follow the 
biosynthesis of DPAP B, a culture of DAP2 cells was pulse 
labeled for 5 min in 35S-H2SO4 and chased for 0, 5,  10, and 
30 min (Fig. 4, lanes 3-6). DPAP B initially appeared as two 
distinct bands of 110 and  113 kD (lane 3) which chased to 
the broad 120-kD species seen in lane 2. A small amount of 
the ll0-kD form remained after a 30-min chase (lanes 2 and 
6).  Longer times of up to 60 min were required to convert 
this  species  to  the  fully  mature  120-kD  form  (data  not 
shown). 
Treatment of the immunoprecipitated samples with endo 
F  (Fig.  4,  lanes  7-10), which  removes N-linked  glycosyl 
residues,  showed that the only detectable difference in the 
species seen in lanes 3-6 is in the amount of N-linked carbo- 
hydrate present on DPAP B.  At each chase time point,  la- 
beled DPAP B  migrated as a  96-kD  species after endo F 
treatment,  which  is  very  close  to  the  molecular  mass 
predicted from the deduced amino acid sequence.  A  small 
amount of a 99-kD species was also detected in lanes 8-10; 
this appears to correspond to one residual carbohydrate chain 
remaining on DPAP B since it disappears upon longer incu- 
bation with endo F  (see Fig. 6). Thus, DPAP B is modified 
in  a  manner similar to  soluble vacuolar proteins,  such as 
CPY, in that its carbohydrate moieties undergo only modest 
extension in the Golgi apparatus, and do not receive the ex- 
tensive outer chain mannose residues found on secreted pro- 
teins such as invertase (Esmon et al.,  1981; Runge,  1988). 
DPAP B Receives Variable Numbers of N-linked 
Glycosyl Residues 
The appearance of two distinct DPAP B species at the earliest 
times in its biogenesis is similar to that seen with invertase, 
which is initially synthesized as several discrete species that 
differ in the number of N-linked glycosyl chains added per 
protein molecule (Esmon et al.,  1981). To determine how 
many of the eight potential sites for N-linked glycosylation 
are modified on DPAP B, limited endo F digestion was per- 
Figure 5. DPAP B is an integral membrane protein. JHRY20-1AA1 
cells containing the DAP2 gene on a multicopy plasmid were con- 
verted to spheroplasts, lysed, and diluted into 100 mM sodium car- 
bonate, pH 11.5. A portion of the total extract (Tot)  was saved, and 
the rest was separated into membrane (Mb) and soluble (Sol) frac- 
tions by centrifugation at 100,000 g for 3 h. The three fractions were 
subjected to SDS-PAGE, and the gel was analyzed by immunoblot- 
ting with DPAP B and phosphoglycerate kinase antibodies and sub- 
sequent incubation with  12~I-protein A. An autoradiogram of the 
immunoblots is shown, with the positions of the protein molecular 
mass standards indicated. 
Figure 6. Time course of endo F digestion. DPAP B was immuno- 
precipitated from CJRY21-3BA1 (sec18)  cells containing DAP2 on 
a multicopy 2-/zm plasmid after 35S labeling for 30 min.  Samples 
were digested with endo F for the times indicated (ON, overnight). 
The different glycosylated species are marked, with the correspond- 
ing number of glycosyl residues shown. 
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from a secl8 mutant at 34°C (see below). Fig. 6 suggests that 
the precursor forms seen in lane 3  of Fig. 4  correspond to 
DPAP  B  with  six  and  seven glycosyl residues  added,  al- 
though forms with five and eight oligosaccharide chains can 
also be seen (Fig. 6, 0-rain time point). Therefore, DPAP B 
can be modified at all eight or as few as five sites, but the 
majority of molecules receives six or seven glycosyl chains. 
DPAP  B Is Not Affected by the AUelic State of  PEP4 
The PEP4 gene function is necessary for the activation of a 
number of vacuolar hydrolases (Jones et al.,  1982).  Muta- 
tions at this locus result in the failure to proteolytically pro- 
cess  the  large molecular  mass,  inactive forms of soluble 
vacuolar  proteins  such  as  CPY  (Rothman  and  Stevens, 
1988). Suarez Rendueles et al. (1981) showed that total DPAP 
(DPAP A  and DPAP B) activity was similar in a wild-type 
strain and a pep4-3 mutant. To examine further the effect of 
a  pep4  mutation  on  DPAP  B,  enzyme  assays  and  im- 
munoprecipitations of DPAP B  were performed using iso- 
genic PEP4 andpep4-A2 strains. No significant effect on the 
activity of DPAP B  was detected in the pep4-A2 strain as 
compared to the PEP4 strain (data not shown),  confirming 
that DPAP B is not synthesized as an inactive precursor. This 
result is consistent with the observation that DPAP B which 
had accumulated in the ER ofsecl8 cells (see below) was en- 
zymatically active (data not shown). Fig. 7 shows that DPAP 
B  immunoprecipitated  from  isogenic  PEP4  and pep4-A2 
strains comigrates before and after digestion with endo E  al- 
though a minor breakdown product, not seen in the pep4-A2 
strain,  was detected in the PEP4 strain after endo F  treat- 
ment. These data argue that the biogenesis of DPAP B is in- 
dependent of the allelic state of the PEP4 gene. 
Early-blocked sec Mutants Accumulate the Precursor 
Form of DPAP  B 
The  temperature-sensitive sec mutations  define  sequential 
steps in the secretory pathway in yeast, since cells carrying 
these mutations are blocked for protein secretion at distinct 
stages (Novick et al.,  1980; Novick et al.,  1981). The local- 
ization of CPY to the vacuole is prevented in sec mutants that 
are blocked at either the ER or Golgi apparatus (secI8 and 
secT, respectively; Stevens et al.,  1982), and the protein ac- 
cumulates as an inactive precursor that lacks Golgi-mediated 
carbohydrate modifications,  secl  cells,  which  at 37°C  are 
blocked at a late secretory vesicle stage of the pathway, trans- 
port CPY to the vacuole at all temperatures. Thus, secretory 
and soluble vacuolar proteins diverge after the sec7-defined 
block and before the secl-blocked  stage. To determine if the 
maturation of DPAP B was affected in these mutants, DPAP 
Figure 7. Effect of a pep4 mu- 
tation  on  DPAP  B.  Strains 
JHRY20-2C  and  JHRY20- 
2CA2 were 35S labeled for 15 
min and chased for 30 min at 
30°C. Labeled cells were col- 
lected,  and DPAP B was im- 
munoprecipitated  and endo F 
treated as before. 
Figure 8~  Effect of sec muta- 
tions on DPAP B. Strains were 
35S  labeled  at  their  nonper- 
missive temperatures  (X2180, 
HMSF176, and HMSF1, 34°C; 
SF294-2B, 38°C) for 15 min, 
chased for 30 min in the pres- 
ence of Na2SO4 at the  same 
temperature, and DPAP B was 
immunoprecipitated as before. 
B was immunoprecipitated after labeling the cells at the non- 
permissive  temperature  of  34°C  (Salminen  and  Novick, 
1987), except for the sec7mutant,  whose restrictive tempera- 
ture is 38°C (data not shown). Wild-type cells contained the 
120-kD mature form of DPAP B at either 34°C  (Fig.  8) or 
38°C  (data  not  shown),  secl  cells  also  contained  mature 
DPAP  B,  whereas  secl8  cells  accumulated  the  DPAP  B 
precursor. Thus, the precursor form seen after a short label- 
ing period (Fig. 4, lane 3) is the ER-form of DPAP B.  The 
sec7 strain accumulated a mixture of core-glycosylated and 
mature forms of DPAP  B.  This suggests that the block in 
transport is at an early stage within the Golgi apparatus such 
that  DPAP B  is only partially processed by the  mannosyl 
transferases (Runge, 1988). This phenotype is similar to that 
seen with invertase, which accumulates as a heterogeneous 
population  of core- and  hyper-glycosylated forms in  sec7 
cells at the restrictive temperature (Esmon et al.,  1981). 
The accumulation of the DPAP B precursor in secl8 and 
secTcells was thermoreversible: after labeling cells at the re- 
strictive temperature, shifting the cultures to 23°C, and chas- 
ing for 3 h  in the absence of new protein synthesis, DPAP 
B was completely converted to the mature 120-kD form (data 
not shown). This result, whichwas also observed with CPY 
accumulated in secl8 and sec7 cells (Stevens et al.,  1982), 
suggests  that  the  accumulated  DPAP  B  precursor  resides 
early in the pathway and is able to transit the Golgi apparatus 
upon shifting to the permissive temperature. 
Early-blocked sec Mutants Accumulate DPAP  B in 
Nonvacuolar Compartments 
To  determine  whether  the  accumulation  of the  DPAP  B 
precursor in sec18 and see7 mutants was correlated with a 
failure to deliver the protein to the  vacuole,  DPAP B  was 
localized by indirect immunofluorescence microscopy. For 
these studies, DPAP B synthesis was placed under the control 
of the inducible GAL/promoter (Johnston and Davis, 1984)i 
allowing analysis of nascent DPAP B synthesis after shifting 
to the nonpcrmissive temperature. A multicopy plasmid con- 
raining  the  GALI-DAP2 gene fusion  was transformed into 
wild-type and sec mutant strains which had been disrupted 
at the chromosomal DAP2 locus. Transformed strains were 
then  shifted  to  the  restrictive  temperatures  in  galactose- 
containing media and incubated for 2 h. This procedure typi- 
cally resulted in a 4-10-fold induction of DPAP B activity rel- 
ative to a strain containing a  single genomic copy of DAF2 
(data not shown).  No DPAP B activity or antigen was de- 
tected when these strains were grown in the absence of galac- 
tose (data not shown). The cells were fixed in formaldehyde, 
spheroplasted, and incubated with affinity-purified DPAP B 
Roberts et al. Biogenesis of a Yeast Vacuolar Membrane Protein  1369 Figure 9.  DPAP B localization by immunofluorescence microscopy. Strains JHRY20-1A (SEC*), CJRY21-3BA1 (secl8), CJRY23-2AA1 
(sec7), and CJRY22-6BA  I (secl), each containing the GAL1-DAP2 gene fusion on a multicopy plasmid, were shifted to their respective 
nonpermissive temperatures and treated for induction of the GAL/promoter for 2 h as described in Materials and Methods. The cells were 
fixed, converted to spheroplasts, and stained with DAPI and afffinity-purified  DPAP B antibody. Cells were viewed by Nomarski differential 
interference optics (A, D, G, and J), and under DAPI (B, E, H, and K) and FITC (C, E  I, and L) excitation wavelengths. 
antibody, followed by FITC-conjugated sheep anti-goat anti- 
body (Fig. 9). Nomarski optics revealed the position of the 
vacuole, and the nucleus was localized by DAPI staining. 
Wild-type cells grown at either 34°C (Fig. 9, A-C) or 38°C 
(data not shown) exhibited fluorescent labeling of DPAP B 
around the perimeter of the vacuole, consistent with the fact 
that  DPAP B  is  a  vacuolar membrane protein.  A  similar 
labeling pattern was seen in secl cells (Fig. 9, J-L), indicat- 
ing that the secl block is later in the secretory pathway than 
the point at which sorting of  vacuolar membrane proteins oc- 
curs. The staining pattern seen in sec18 (Fig. 9, D-F) and 
sect (Fig. 9, G-I) cells was distinctly nonvacuolar. Interest- 
ingly, the sec18 strain showed DPAP B staining around the 
nucleus, apparently in the nuclear envelope, which probably 
reflects the fact that the nuclear envelope and the ER are con- 
tinuous membranes.  These data indicate that transport of 
The Journal of Cell Biology, Volume  108, 1989  1370 DPAP B to the vacuole is prevented in sec mutants that are 
blocked in protein transport early in the secretory pathway. 
Discussion 
DPAP B is the first protein of the yeast vacuolar membrane 
whose structure and biosynthesis has been characterized. Of 
the vacuolar membrane-associated activities that have been 
described  in  yeast,  only the  proton-translocating  ATPase 
(Uchida et al.,  1985; Kane et al., 1989) and u-mannosidase 
(Yoshihisa et al.,  1988) have been extensively characterized 
biochemically. The proton-translocating ATPase is a multi- 
meric  enzyme consisting  of both  integral  and  peripheral 
membrane  proteins  (Kane  et al.,  1989).  ~Mannosidase, 
which is frequently used as a marker for the vacuolar mem- 
brane, is efficiently removed from membranes by treatment 
with high-pH sodium carbonate, suggesting that it is periph- 
erally associated with the vacuolar membrane (Yoshihisa  et 
al.,  1988). Thus, DPAP B appears to be a more appropriate 
marker for intrinsic vacuolar membrane proteins. 
In a previous biochemical study, DPAP B was reported to 
be a 40-kD protein (Garcia Alvarez et al., 1985). In the pres- 
ent work we have found that DPAP B is a 120-kD glycopro- 
tein, that this species is absent from a strain with a disruption 
at DAP2,  and that the DAP2  sequence encodes a  protein 
predicted to have a molecular mass of  96,429 D, which corre- 
sponds closely to that actually observed for deglycosylated 
DPAP B. The 40-kD species seen previously may have been 
a contaminating protein or a proteolytic fragment of DPAP B. 
As  is  the  case  for  the  soluble  vacuolar  protein  CPY 
(Stevens et al., 1982), the delivery of DPAP B to the vacuole 
is blocked in sec mutants that affect the early stages of the 
secretory  pathway,  sec18  (ER-blocked)  and  sec7  (Golgi- 
blocked) cells accumulate DPAP B in nonvacuolar compart- 
ments at the  restrictive temperature.  However, secl  ceils, 
which are blocked at a late secretory vesicle stage, transport 
DPAP B to the vacuole at all temperatures, indicating that 
DPAP B is transported directly from the Golgi apparatus to 
the vacuole. This rules out models in which vacuolar mem- 
brane proteins are first delivered to the plasma membrane, 
and  suggests that,  in yeast,  soluble and membrane-bound 
proteins traverse the  same compartments of the  secretory 
pathway en route to the vacuole (Stevens et al.,  1982), as is 
the case for the delivery of proteins to the lysosome in mam- 
malian cells (Griffiths et al.,  1988). 
The activity and apparent molecular mass of DPAP B are 
unaffected by a null mutation at the PEP4 locus. DPAP B is 
active at all stages of its transport and does not appear to un- 
dergo proteolytic cleavage upon delivery to the vacuole. In 
this respect, DPAP B differs from the soluble vacuolar hydro- 
lases studied thus far, which are synthesized as zymogens 
and are activated in a PEP4-dependent fashion (Rothman and 
Stevens, 1988). Interestingly, the other vacuolar membrane 
activities  that  have  been  examined,  i.e.,  ot-mannosidase 
(Jones  et al.,  1982)  and  the  proton-translocating ATPase 
(Yamashiro,  C.,  and T.  Stevens, unpublished results),  are 
also PEP4 independent. 
Overproduction of the soluble vacuolar proteins CPY and 
proteinase A results in their secretion, presumably due to the 
saturation of a component of the sorting apparatus (Stevens 
et al.,  1986; Rothman et al.,  1986). This observation pro- 
vided a means of isolating mutations that disrupt the sorting 
process, both linked and unlinked to the structural genes of 
the soluble vacuolar proteins (Vails et al.,  1987;  Rothman 
and Stevens,  1986; Bankaitis et al.,  1986; Robinson et al., 
1988;  Rothman  et  al.,  1989).  20-fold  overproduction of 
DPAP B does not result in increased cell surface activity of 
this enzyme (our unpublished results). However, at this level 
of expression DPAP B does suppress the defect in u-factor 
maturation of a MATtx stel3 mutant (Sprague, G., and I. Her- 
skowitz,  unpublished observation; Julius  et al.,  1983).  A 
reasonable interpretation of this result is that DPAP B is mis- 
localized into the late secretory pathway when overproduced, 
allowing it to encounter and process the c~-factor precursor 
to the mature form. Based on this assumption,  mutations 
have been isolated that result in secretion of mature ct-factor 
in a stel3 background. These mutants do not cause DPAP B 
to be overproduced, and may define genes that encode com- 
ponents of the sorting apparatus for vacuolar membrane pro- 
teins (Pohlig, G., and T.  Stevens, unpublished results). 
The sorting signal(s) that directs membrane proteins to the 
vacuole has yet to be defined. The sorting information could 
reside in any of three distinct domains; i.e., the cytoplasmic, 
membrane,  and/or  lumenal  domains.  Moreover,  each  of 
these domains has been shown to be important for proper in- 
tracellular targeting of particular membrane proteins.  The 
lumenal domains of the influenza virus hemagglutinin and 
vesicular stomatitis virus G protein have been implicated as 
important for the polarized secretion of these proteins to the 
apical and basolateral membranes, respectively (Roth et al., 
1987; McQueen et al.,  1987). Retention of the coronavirus 
E1  glycoprotein in the Golgi apparatus requires a  specific 
transmembrane region (Machamer and Rose, 1987), and an 
intact cytoplasmic tail  is necessary for endocytosis of the 
LDL and transferrin receptors (Davis et al.,  1986; Rothen- 
berger et al.,  1987).  Preliminary experiments have shown 
that the cytoplasmic tail and transmembrane region of DPAP 
B contain vacuolar sorting information; i.e., fusion of the 
NH:-terminal 47 residues of DPAP B to the NH2 terminus 
of the cytoplasmic form of invertase results in the delivery 
of  this hybrid protein to the vacuolar membrane (Roberts, C., 
and T. Stevens, unpublished observation). This approach has 
been previously used to map the sorting domains of CPY 
(Johnson et al.,  1987) and proteinase A  (Klionsky et al., 
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Figure 10.  Comparison of DPAP B and DPAP A. Models for the 
disposition of the two proteins in their respective membranes are 
shown, with their subcellular locations listed at right. The NH2 
and COOH termini of the proteins are indicated, as are the regions 
of extensive amino acid identity, with the percentage of identical 
amino acids given. 
Roberts et al. Biogenesis of a  Yeast  Vacuolar Membrane Protein  1371 1988). Further experiments are aimed at the identification of 
the specific amino acid residues in this region that are neces- 
sary  for targeting  DPAP B to the vacuole. 
The  DNA  sequence  of the  STE/3  gene,  which encodes 
DPAP A (Julius et al., 1983), has recently been determined 
(Flanagan,  C.,  and J.  Thorner,  personal  communication). 
The deduced amino acid sequence predicts a protein of 931 
amino acids with striking  similarities to DPAP B (Fig.  10). 
Both proteins are predicted to have type II membrane topolo- 
gies, with short cytoplasmic tails and ,0800 amino acid lu- 
menal domains. The lumenal domains of these proteins are 
very similar; in particular,  the COOH-terminal 240 amino 
acids are 48 % identical,  presumably  reflecting  the similar 
enzymatic  functions of these proteins in vitro and in vivo 
(Julius  et al.,  1983).  However, the cytoplasmic  and trans- 
membrane  domains  are  unrelated,  possibly  reflecting  the 
different subcellular addresses of DPAPA and DPAP B. This 
sorting signal hypothesis can be tested by exchanging these 
segments of the two proteins, an approach that has been use- 
ful in studying the sorting of membrane proteins in polarized 
cells (Roth et al.,  1987;  McQueen et al.,  1987). 
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